GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (FRA:PI3) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Gubra AS (FRA:PI3) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jul. 08, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Gubra AS's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Gubra AS's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Gubra AS's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Gubra AS's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Gubra AS  (FRA:PI3) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Gubra AS Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Gubra AS's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (FRA:PI3) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.

Gubra AS Headlines

No Headlines